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Abstract
Objective
To examine how the first randomised controlled trials (RCTs) evaluating the efficacy of cho-
lesterol-lowering diets in the secondary prevention of coronary heart disease were inter-
preted in reviews of the literature prior to the National Institutes of Health consensus
conference in 1984.
Design
Claim-specific citation network analysis was used to study the network of citations between
reviews and RCTs over a defined period (1969–1984). RCTs were identified and classified
according to whether their conclusions supported or opposed the use of dietary fat modifica-
tion/restriction in the secondary prevention of coronary heart disease. Each review pub-
lished in this period that cited any of the RCTs was classified as supportive, neutral, or
unsupportive to the use of dietary fat modification based on a quotation analysis of its evalu-
ation of the findings of these RCTs. Citation bias and underutilisation were detected by
applying a comparative density measure, in-degree centrality, and out-degree in a series of
sub-graph analyses.
Results
In total, 66 unique publications were identified (four RCTs—one supportive, three unsuppor-
tive; 62 reviews—28 supportive, 17 neutral, 17 unsupportive). On average, supportive
reviews underutilised the available RCTs to a greater degree than other reviews. Amongst
the supportive group, citation bias was common—23 (82%) reviews cited only the one RCT
that was supportive.
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Conclusion
Most reviews that disseminated a supportive evaluation of the results of RCTs in the context
of secondary prevention cited only data that supported this position.
Introduction
In 1961, the American Heart Association published guidelines recommending that people who
have had one or more atherosclerotic heart attacks should reduce their intake of saturated fatty
acids and modestly increase that of polyunsaturated fatty acids [1]. The rationale was an early
version of the diet–heart hypothesis, that dietary intake of saturated fatty acids, by increasing
total serum cholesterol, contributes to coronary heart disease (CHD) via the development of
atherosclerosis, while polyunsaturated fatty acids decrease serum cholesterol and lower the
risk of CHD [2]. In the 1950s, this theory was supported by: (i) epidemiological evidence of an
association between fat intake, particularly saturated fatty acids intake, and raised serum cho-
lesterol levels; (ii) an association between serum cholesterol and coronary incidence and mor-
tality; (iii) short-term metabolic ward trials that suggested that saturated fatty acids increased
serum cholesterol while polyunsaturated fatty acids appeared to modestly lower serum choles-
terol [3].
However, some scientists warned of the dangers of mistaking correlation for causation, par-
ticularly in population studies [4] and in a multifactorial disease such as CHD [5, 6]. By the
time that the guidelines were issued, no randomised controlled trial (RCT) had tested the link
between the consumption of different types of fat and coronary risk in secondary prevention
(i.e., after a clinical manifestation of CHD), but, in the 1960s, five RCTs examined this. The
Los Angeles Veterans Administration Diet Study [7] combined secondary prevention and pri-
mary prevention (i.e., before the development of CHD), but was generally regarded as relevant
only to primary prevention due to the way the authors stratified their data and presented their
findings. Four other trials specifically examined the effect of a modified diet in the secondary
prevention of CHD in patients who had experienced a recent myocardial infarction: the
Research Committee Low-Fat Diet Study [8] examined total fat restriction, while the Rose Corn
Oil Study [9], the Oslo Diet-Heart Study [10], and the Medical Research Council’s Soya-bean Oil
Study [11] examined the impact of restricting saturated fatty acids and increasing polyunsatu-
rated fatty acid intake. These were the only published secondary prevention RCTs until the
partial publication of the Sydney Diet–Heart Study [12] in 1978, which only published results
concerning all-cause mortality. The full results of that trial on cardiovascular disease (CVD)
and CHD mortality were recently recovered and re-analysed by Ramsden et al. [13], who
found a significant harmful effect of replacing saturated fatty acids with polyunsaturated fatty
acids on all-cause mortality, CVD mortality, and CHD mortality.
The four RCTs published in 1965 [8, 9], 1966 [10], and 1968 [11] had similar methodolo-
gies, and were published in major journals, but produced discrepant findings (S1–S4 Tables).
The Oslo study, published in 1966, found significantly lower levels of fatal reinfarction, non-
fatal reinfarction, and angina pectoris in the intervention group, but found no significant rela-
tionship between diet and sudden death or all-cause mortality [10]. The other three studies all
returned equivocal or negative results regarding reinfarction, coronary mortality, cardiovascu-
lar events, and all-cause mortality. The author of the Oslo study regarded his results as support-
ing dietary fat modification in secondary prevention, while the authors of the other studies
regarded their results as evidence against such treatments.
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In December 1984, the National Institutes of Health (NIH) gathered a panel of experts to
resolve whether the link between raised serum cholesterol and heart attack was causal, and
under what circumstances dietary or drug therapy should be initiated [14]. After reviewing the
available evidence, the panel concluded that an elevated serum cholesterol level is a cause of
CHD and that lowering it is protective. To lower serum levels of cholesterol, the panel recom-
mended that all men, women, and children over 2 years of age should eat a diet consisting of
no more than 30% fat, should reduce their intake of saturated fatty acids to less than 10% of
total calories, and should increase their intake of polyunsaturated fatty acids to 10% of total
calories. Specifically, on secondary prevention, the panel concluded:
“Studies are available that indicate a beneficial effect of treating high cholesterol levels in
individuals with preexisting clinical disease (secondary intervention) . . . It is encouraging
that the progression of established lesions may be retarded by appropriate dietary and drug
therapy” (p.2084)
The conference was widely regarded as bringing a (temporary) end to the controversy over
both the relationship of cholesterol with CHD and the relationship between dietary fats and
CHD [15].
Yet, by 1984, the four RCTs discussed previously remained the only available RCTs with
data on the effect of dietary modification on coronary mortality and morbidity in secondary
prevention. However, the results of these trials were conflicting–an evaluation supported both
by the directors of each study and by recent meta-analyses [16–19]. According to Harcombe
et al. [16], the NIH advice was not supported by the available RCTs, neither in primary or sec-
ondary prevention. As can be seen in the risk-ratio analysis in the supplement (S4 Table), the
evidence from these RCTs available prior to 1984 leads to no clear conclusion as to whether
dietary modification is an appropriate treatment in secondary prevention. Recent meta-analy-
ses also agree that, when the findings of these four trials are considered together, no significant
difference exists on the “hard” clinical end-points–the incidence of myocardial infarction, fatal
CHD, and all-cause mortality–between the intervention and control [16–19].
The present study examines how these four trials were utilised in the literature and their
impact on published scientific opinion regarding the case for dietary fat modification/restric-
tion in the secondary prevention of CHD, prior to the NIH consensus conference. By using a
modified version of claim-specific citation network analysis, a methodology developed by
Greenberg [20], it maps and evaluates the network of review papers that cited these RCTs over
a defined period (1969–1984); the date by which all relevant RCT data would have been avail-
able to reviewers to the start of the NIH conference. The rationale for examining how these
studies were cited is the claim that the diet–heart controversy stems from selective citation [21,
22]. In 1992, Uffe Ravnskov, in one of the first published demonstrations of citation bias,
examined 22 cholesterol-lowering trials and found that supportive trials were cited almost six
times as often as others [21]. In three highly-cited reviews associated with dietary policy [23–
25], he went on to document citation bias and quotation bias, which describes the erroneous
or selective interpretation of experimental findings [22]. Finally, in a response to an article in
the BMJ in 2003, he claimed that belief in the diet–heart hypothesis was kept alive by selective
citation [26].
The present study tested these claims by examining how dietary RCT results were cited in
reviews during the period leading up the publication of dietary guidelines and closure of con-
troversy, following Greenberg’s [20] finding that reviews tend to be the major propagators of
information regarding the findings of primary studies. To do so, it examines two outcomes of
selective citation: citation bias–the selective citing of data supporting a particular outcome
Selective citation of evidence regarding fat-controlled diets in the secondary prevention of CHD
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[20]; and research underutilisation–when authors fail to reference all available data relevant to
a specific claim. These are outcomes of sub-optimal citation practices that distort the evidence
base by inflating the influence of some studies while under-representing others [20, 27]. To
detect these factors, network analysis was used to document citation bias and underutilisation
by mapping the citation links between RCTs and reviews that were themselves classified by
quotation analysis.
Materials and methods
Study selection
To be included, a trial had to be a unifactorial RCT that: (i) was published before 1984; (ii)
examined the effect of dietary fat restriction (<30% of total calories derived from dietary fat)
OR dietary fat modification (replacing saturated fatty acids with polyunsaturated fatty acids)
on coronary benefit/risk in the secondary prevention of CHD; (iii) published data on sample
numbers AND serum cholesterol changes AND mortality and morbidity figures regarding
incidence of myocardial infarction, coronary mortality (including myocardial infarction and
sudden death), and all-cause mortality; (iv) included only patients with established CHD (myo-
cardial infarction, angina pectoris); (v) a minimum intervention and follow-up period of 12
months.
RCTs were identified via a literature search on Web of Science via the ‘all database’ function
with the following Boolean string (“dietary fat” OR “fatty acids” OR “saturated fat” OR “low fat
diet” OR “cholesterol lowering diet” OR “modified fat diet” OR “restricted fat diet” OR “corn
oil” OR “soya bean oil” OR “unsaturated fat” OR “linoleic acid”) AND (“coronary heart dis-
ease” OR “ischaemic heart disease” OR “myocardial infarction” OR “cardiovascular disease”
OR “atherosclerotic heart disease”) AND (“trial” OR “controlled trial” OR “randomised con-
trolled trial” OR “intervention trial” OR “clinical trial”), limited to publications between 1950
and 1984. This returned 244 publications across four databases in March 2017 (MEDLINE,
Web of Science Core Collection, BIOSIS Citation Index, FSTA1 - the Food Science Resource). An
additional examination of trials identified by recent systematic reviews and meta-analyses was
also conducted to ensure all relevant studies were identified [16–19]. After screening publica-
tion titles and abstracts, 19 trials were identified as potentially relevant. After reading these,
four RCTs were identified that met the inclusion criteria, all of which were published in the
decade after the publication of the American Heart Association guidelines. The findings of
these four RCTs were published in seven papers: the results of the Oslo Trial were published in
four journals [10, 28–30]. These were merged, reducing the primary source studies to four.
The results of these trials are included in the analysis in the supplement (S1–S4 Tables).
One trial, the Los Angeles Veterans Administration Diet Study [7], was omitted due to the
inability to assess data on the effectiveness of dietary modification in secondary prevention
due to the way the authors stratified their data and reported their findings. This was further
justified by the prevailing opinion of the scientific community as expressed in reviews, which
appeared to regard it relevant only to primary prevention, and its exclusion from meta-analy-
ses covering secondary prevention specifically [18]. Another trial, the Sydney Diet–Heart Study
[12], was omitted because only results on all-cause mortality were reported within the time
frame and because it remained uncited in the literature by reviews until 1985 [30]. The Finnish
Mental Hospital Study [31], a commonly-cited study in this period, was excluded on the basis
that it was not an RCT; it was a “cross-over” trial in two mental hospitals and combined sec-
ondary and primary prevention. Further, it was not a standard cross-over trial: the patient
groups were not the same in the diet arm and the control arm, no blinding was mentioned,
and investigators re-coded deaths post-hoc. Bierenbaum et al.’s [32] St Vincent’s Hospital
Selective citation of evidence regarding fat-controlled diets in the secondary prevention of CHD
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Study was excluded because of the lack of appropriate randomisation due to the assigning of a
control group post-hoc that had “similar characteristics” to the intervention. Five trials were
excluded on the basis of being primary prevention trials [33–35] and/or multifactorial [36–37],
and six early secondary prevention trials were excluded due to a lack of appropriate randomi-
sation and/or control [38–43].
Review papers, published in academic journals in English between 1969 and 1984 and
which cited one or more of the studies, were identified by searching Scopus and Web of Science
using indexed citation links associated with the relevant RCTs. To be included, a paper had to
be a review or an extended editorial (with at least one citation) published in an academic jour-
nal within which the coronary mortality and morbidity results of the identified RCTs were dis-
cussed. During this period, only narrative reviews covered this topic, and none described a
systematic search strategy. Excluded from analysis were letters, notes, book chapters, other pri-
mary articles, any paper not published in an academic journal, and any review that cited the
RCTs without discussing mortality and morbidity. The search in Scopus returned 110 citing
articles, of which 30 met the inclusion criteria. The search on Web of Science returned 215 cit-
ing articles, from which an additional 32 reviews were recovered that met the inclusion crite-
ria. In total, 62 citing reviews were included in the analysis [44–105].
Classification of papers
The RCTs were classified using ‘quotation analysis’ [20, 22, 27] according to whether the find-
ings were evidence for or against the use of dietary fat modification/restriction in the second-
ary prevention of CHD. Quotations from the papers were collected to enable papers to be
classified by the authors’ interpretation of their findings and these are reproduced in the sup-
plement (S5 Table). For example, the authors of the Rose Corn Oil Study, an unsupportive trial,
concluded that “under the circumstances of this trial corn oil cannot be recommended in the
treatment of ischaemic heart disease” (p. 1533). By contrast, the author of the Oslo Study, the
only supportive trial, concluded that the observed “reduction of the serum cholesterol level
associated with a reduced CHD relapse rate strongly suggests a cause and effect relationship”
(p. 79).
Reviews were similarly classified by quotation analysis by the authors’ evaluation of the
RCT evidence. Quotations were identified either in the passage in which RCTs were cited or
were stated explicitly in a conclusion, and these are reproduced in the supplement (S5 Table).
Reviews were then classified into one of three categories: supportive reviews contained state-
ments implying that the available trial evidence supported dietary intervention; neutral reviews
contained statements highlighting the conflicting nature of the trial results and contained
no statement either supporting or opposing dietary intervention; unsupportive reviews con-
tained statements implying that the available trial evidence did not support the use of dietary
intervention.
Network data
Each paper was given an identifier code (Vn). All authors, title of paper, year of publication,
paper type (RCT or review), and classification were recorded to identify each vertex in a ‘node
list’ format (S6 Table). This attribute information was used to examine the relationship
between classification variables and citations behaviours. The citations to (incoming edges)
and from (outgoing edges) all papers were recorded. The bibliographies of each review were
screened to ensure that all citations to RCTs were identified within this sample. Citation infor-
mation on the relationship between papers was recorded in an ‘edge list’ format in an Excel
spreadsheet (S7 Table). This describes a network as a set of vertices (papers) connected by
Selective citation of evidence regarding fat-controlled diets in the secondary prevention of CHD
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‘edges’ (citation links). From these data, a graph was constructed and analysed using R’s ‘stat-
net’ package [106, 107] and visualised in Gephi [108]. Citation information was converted into
an adjacency matrix that records edges (citations) between vertices (papers):
Gij ¼

1 if there is an edge between vertices i and j
0 otherwise
A graph [G] was constructed of the vertex set [V] and edge set [E]:
G ¼ ðV;EÞ
The vertices were coloured by classification and sized by in-degree, labelled by number
assigned in the bibliography of this paper, and visualised initially using Gephi’s ‘ForceAtlas 2’
algorithm [108, 109] and later manually realigned in sub-graphs.
Two outcome measures–citation bias and research underutilisation–were used. Following
Greenberg [20], citation bias refers to the act of citing only evidence of a particular classifica-
tion. For example, if paper A references only supportive studies and no contradictory studies
then it displays citation bias. Citation bias only describes the most extreme cases of evidence
selection, but any underutilisation may create distortions in the literature–i.e., if reviews fail to
use all relevant evidence even if a clear preference for a particular outcome does not influence
selection. To detect these, the unit of analysis is the citation pathway, and the occupied citation
pathway (an edge linking two vertices) is compared to all possible citation pathways between
reviews and RCTs. Three measures are used to measure citation bias and underutilisation–a
novel modified density measure, in-degree centrality, and out-degree.
The network in this study is an example of a directed acyclic network [110] because papers
can only cite previously published papers and can never cite future literature or cite them-
selves. To know the density, the proportion of potential edges present, a measure of network
connectivity is needed. Generally, if P is a set of primary studies, S a set of reviews, and E the
number of edges from S to P, then
D ¼
E
jSjxjPj
captures the number of times that a set of reviews cites a set of RCTs as a proportion of the
maximum possible number of citations, allowing comparison between different classifications
of review. Thus, this equation can be used to understand divergent utilisation of primary data.
In-degree reflects how often a study has been cited. The in-degree of a vertex is the number
of edges from other vertices to that vertex, and, for a vertex i, is given by:
kini ¼
Xn
j¼1
Gij
Out-degree reflects the number of references from a particular review. The out-degree of a
vertex is the number of edges from that vertex to other vertices, given by:
koutj ¼
Xn
i¼1
Gij
To establish citation bias, the network was divided into three sub-graphs of the RCTs with
reviews of each classification (supportive, neutral, unsupportive) and only edges from reviews
to RCTs. The vertices that cite only RCTs of a particular classification were then counted–pro-
viding an exact account of citation bias and research utilisation.
Selective citation of evidence regarding fat-controlled diets in the secondary prevention of CHD
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Finally, a Pearson’s chi square test was performed on the distribution of citations to these
four RCTs between the three classifications of review to establish whether the difference in
citation behaviour is significant or simply the product of chance.
Results
Of the four RCTs, one was supportive of dietary intervention [10] in the context of secondary
prevention, while three were not [8, 9, 11]. Between 1969 and 1984, these were cited in 62
reviews, 28 of which were supportive of dietary intervention [78–105], 17 were unsupportive
[61–77], and 17 ‘neutral’ reviews came to no clear conclusion on this issue [44–60]. Of these,
28 were published in the first 7 years (12 supportive; 12 neutral; four unsupportive), and 34 in
the next 8 years (16 supportive; five neutral; 13 unsupportive).
Fig 1 shows the citation network. Of the four RCTs, the most cited was the Oslo study with
57 citations. This was the only one of the four RCTs that was supportive of dietary interven-
tion, but the other three (unsupportive) RCTs together attracted a similar number of citations
(32 to MRC Soya-bean, 15 to Rose Corn, 17 to Research Committee Low-fat). Here, citation
bias, particularly by supportive reviews, is signified by the many studies that cite only the Oslo
Fig 1. Citation network mapping the citations from reviews to RCTs testing dietary fat modification in the secondary prevention of CHD (n = 66; m = 121).
Citation network graph with four RCTs connected to 62 citing reviews by a total of 121 citations. Each vertex represents a paper and the integer label corresponds to a
paper in this paper’s bibliography. The colour of a vertex corresponds to a study’s classification (blue is supportive, green is neutral, and red is unsupportive). Vertex size
is proportional to in-degree (total number of incoming citations). Each edge corresponds to a specific citation link and the direction of the edge is established by the
direction of the arrow head. Visualised with Gephi’s ‘Force Atlas 2’ algorithm [109].
https://doi.org/10.1371/journal.pone.0197716.g001
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study. Clearly, the distribution of citations to these studies is uneven. A high proportion of the
reviews (27 of 62; 43%) cited only one of the RCTs, 20 cited two of them, six cited three and
only nine cited all four. Nevertheless, taking the three unsupportive trials together, supportive
trials are cited 57 times and unsupportive trials 64 times. Overall the graph has a density D of
0.49 –indicating only 49% of the possible citations exist between reviews and these RCTs.
To create an exact account of the utilisation of the primary RCT data by reviews, three sub-
graphs were constructed including only reviews of a particular classification (supportive, neu-
tral, unsupportive) and only edges from reviews to RCTs.
Neutral reviews
Of the neutral reviews (Fig 2), one cites only supportive data, which represent the only case of
citation bias in this group. Overall the density of this sub-graph (D = 0.68) is higher than that
of the network as a whole, indicating that reviews which cited more of the available primary lit-
erature were more likely to come to no clear conclusion than the average. While the Oslo Study
received most citations (17), its influence is nearly rivalled by the MRC Soya-bean Study, which
Fig 2. Sub-graph mapping the citations from neutral reviews to RCTs testing cholesterol lowering diets in the secondary prevention of CHD (n = 21; m= 46).
This graph is composed of four RCTs connected to 17 citing reviews by a total of 46 citations. Each vertex represents a paper and the integer label corresponds to a paper
in this paper’s bibliography. The colour of a vertex corresponds to a study’s classification (blue is supportive, green is neutral, and red is unsupportive). Vertex size is
proportional to in-degree (total number of incoming citations). Each edge corresponds to a specific citation link, the direction of the edge is established by the direction
of the arrow head, and the colour of an edge indicates the classification of the cited article. This was visualised manually in Gephi [108] by lining up reviews in the
centre, placing supportive the RCT below and the unsupportive RCTs on top.
https://doi.org/10.1371/journal.pone.0197716.g002
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received 15; the Rose Corn Oil Study and the Research Committee Low-fat Study were each cited
seven times. Six of the reviews cited all four RCTs and only one cited only one of them. Thus,
compared to the whole network, neutral reviews were more likely to fully utilise the available
RCT evidence and less likely to cite only one RCT.
Unsupportive reviews
The sub-graph of unsupportive reviews (Fig 3) had a density of 0.56. The Oslo study and the
MRC study were each cited 12 times by unsupportive reviews, the Rose study six times and the
Low-fat study eight times. Five of the 17 unsupportive reviews cited only evidence that sup-
ported their position. Three reviews cited only the supportive trial, implying a difference of
interpretation between the reviewers and the authors of that study. Therefore, in total eight
reviews (47%) exhibit citation bias for trials of a particular outcome. Three reviews cited just
one RCT and two cited all four; most (nine) cited two of the RCTs.
Fig 3. Sub-graph mapping the citations from unsupportive reviews to RCTs testing cholesterol lowering diets in the secondary prevention of CHD (n = 21; m=
38). This graph is composed of four RCTs connected to 17 reviews by a total of 38 citations. Each vertex represents a paper and the integer label corresponds to a paper
in the reference list. The colour of a vertex corresponds to a study’s classification (blue is supportive and red is unsupportive). Vertex size is proportional to in-degree
(total number of incoming citations). Each edge corresponds to a specific citation link, the direction of the edge is established by the direction of the arrow head, and the
colour of an edge indicates the classification of the cited article.
https://doi.org/10.1371/journal.pone.0197716.g003
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Supportive reviews
Compared with the neutral and unsupportive reviews, the 28 supportive reviews (Fig 4) used
much less of the available primary data (D = 0.33 vs 0.56 in unsupportive reviews and 0.68 in
neutral reviews). All 28 cited the single supportive RCT, the Oslo study, while the three other
RCTs were cited only nine times. In all, 23 of the supportive reviews (82%) cited only the Oslo
study, and only five of these reviews cited any of the other RCTs (two cited one other, two
cited two others, and just one cited all four RCTs).
Table 1 gives the distribution of citations to RCTs from different classifications of review.
A Pearson’s chi square test was performed to test whether this distribution is significantly
related to classification or the product of chance. The validity of a chi square test depends on
the conditions that the expected count is greater than 5 for at least 80% of the cells, and that
each cell has a count of at least 1: these conditions were both satisfied. The test result estab-
lishes that the difference observed in the citation behaviours between reviews is significant
(Χ 2(6, N = 121) = 18.19, p = 0.006).
Discussion
This study examined the propagation of experimental evidence derived from RCTs in reviews
of the literature during a period of scientific controversy. This was not a minor academic
Fig 4. Sub-graph mapping the citations from supportive reviews to RCTs testing cholesterol lowering diets in the secondary prevention of CHD (n = 32; m= 37).
This graph is composed of four RCTs connected to 28 citing reviews by a total of 37 citations. Each vertex represents a paper and the integer label corresponds to a paper
in the reference list. The colour of a vertex corresponds to a study’s classification (blue is supportive and red is unsupportive). Vertex size is proportional to in-degree
(total number of incoming citations). Each edge corresponds to a specific citation link, the direction of the edge is established by the direction of the arrow head, and the
colour of an edge indicates the classification of the cited article.
https://doi.org/10.1371/journal.pone.0197716.g004
Table 1. Contingency table of the distribution of citations from three different classifications of review to four secondary prevention RCTs.
Oslo [10] MRC [11] Rose [8] Research Committee [9] Row Totals
Neutral 17 15 7 7 46
Unsupportive 12 12 6 8 38
Supportive 28 5 2 2 37
Column Totals 57 32 15 17 121
https://doi.org/10.1371/journal.pone.0197716.t001
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dispute; this was an issue of considerable public health importance at the time. It documented
a major divide between reviews over what the available empirical evidence was, how it should
be evaluated, and what the implications were for dietary intervention in the secondary preven-
tion of CHD. Overwhelmingly, reviews that disseminated a supportive evaluation of the results
of RCTs in the context of secondary prevention cited only data that supported this position.
They did not critique the discrepant data, they simply ignored it, or were ignorant of its exis-
tence. Other reviews were overall much more balanced in their citation and this difference in
citation behaviour appears to explain divergence of opinion on this matter.
While the Oslo trial, a supportive RCT, was by far the most influential, its influence was not
uniform amongst different classifications of review. This was the only RCT to arrive at statisti-
cally significant findings. A number of studies have reported evidence of a bias in the literature,
in that studies with statistically significant results tend to be cited more often than studies that
report non-significant or equivocal results [21, 111–114]. However, such a bias for significant
outcomes fails to explain the discrepancies between the citing behaviours of different groups.
The degree of utilisation of primary data by reviews appeared to be mediated by a review’s
position, with supportive reviews likely to use less of the available RCT evidence than others.
Again, this may be explained by a preference for statistically significant findings, but, as dis-
cussed, there are problems with this explanation. An alternative hypothesis may be that the
shape of the literature itself determines the selection of RCT evidence–where reviewers find
evidence from other papers. In this case, if a reviewer believes another paper to have identified
all relevant evidence, they may replicate selective citation. This has been described by Green-
berg’s information cascade hypothesis–where chains of citations from one paper to another
lead researcher’s to only a segment of the available evidence, if those authors simply follow bib-
liographies [20]. This hypothesis may be supported by Simkin and Roychowdhury’s [115]
finding that on average only 20% of the cited literature in bibliographies has been read by the
authors. If scientists do tend to gain their information about primary studies by reading other
papers rather than the originals, this is particularly worrying in this case due to the amount of
bias in the selection of evidence by reviews and the degree of underutilisation. Collectively, the
citing reviews studied in this paper have been cited 2,157 times (by August 2017) according to
Web of Science (supportive reviews 651; neutral 489; unsupportive 1017); however, without
further analysis, no statement can be made about what influence these reviews had on the
literature.
Thirdly, citation bias was considerably more prevalent in supportive reviews. This seems to
be an example of homophily—the tendency for a vertex to share an edge with a vertex with
which it shares an attribute, and is consistent with Heider’s [116] theory that individuals
choose relationships that reinforce existing preferences and beliefs. However, this fails to
explain the unsupportive reviews, which we would expect to only cite evidence that supports
their perspective. We did not observe this.
Fourthly, few reviews cited all relevant data–with underutilisation common. In the period
concerned, conventions governing systematic search strategies were in their infancy. The
reviews were mostly of the narrative form, a type that has been criticised for selection bias and
the promotion of partial perspectives of the evidence. Indeed, one finding of this paper is that
reviews in this field were poor at considering all the available empirical evidence. Bushman
and Wells [117] offer experimental evidence of the role of availability bias (a heuristic that
describes the tendency of humans to judge the prevalence/probability of an event by the ease
in which they are able to recall certain information), which the authors argue influence the
propensity for selection bias in narrative reviews compared with systematic reviews and meta-
analysis, which impose a rigorous structure of literature searching and study evaluation on the
researcher. Importantly, narrative reviews are not the only papers in which citation bias has
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been documented, Robinson and Goodman [118] documented significant citation bias
amongst RCTs addressing the same question and may be explained by the lack of systematic
search strategies amongst these papers.
Finally, did the selection of evidence itself explain the divergence of opinion amongst
reviews? That is, were these authors only aware of the data they cited? If so, it would seem
those underutilising the literature arrive at positions that are based on partial perspectives. Or
did pre-existing opinions held by reviewers determine their selection of evidence? That is,
were opinions formed first and evidence selected afterwards? If so, this would be a case of con-
firmation bias. Here, we see the complexities involved in attempting to determine which direc-
tion the arrow of causality points–is evidence formative in scientific opinion? Or do pre-
existing opinions dictate the evidence we choose to examine?
The major findings offer an alternative to the prevailing notion of what a scientific contro-
versy is, i.e. that scientific disagreement stems from different theoretical positions, where
researchers looking at the same evidence can justifiably come to different conclusions [119].
Disagreement in this instance appears to stem from the selection of different sources of evi-
dence, rather than the possession of different theoretical perspectives. Trinquart et al. [27]
came to similar conclusions when examining the controversy about the suggested benefits of
restricting dietary salt intake. They observed “two almost distinct and disparate lines of schol-
arship, one supporting and one contradicting the hypothesis” (p.57)–lines that relied on differ-
ent sources of evidence and which differed in their citing behaviour.
Implications
Scientists, at present, are concerned at a wide range of factors that they understand to be dis-
torting science. These include publication bias [120, 121], problems with replication [122], and
citation biases [20, 21, 27, 111–114]. Their combined effect has undermined faith in the idea
that our sciences are self-correcting, and increasingly commentators fear that our system of
knowledge production is broken. De Solla Price [123] and later Ravetz [124] raised concerns
that as science grew it may experience ‘senility’–with the evidence base and citing literature
growing too large for effective quality control, but it is a view that is gaining increasing atten-
tion [125].
This study focused on citation bias, a structural bias that leads to distortions of authority,
whereby some positions are held up by the inflated authority of supporting primary studies
and where scientists do not interact with, and in some cases may be unaware of, rival perspec-
tives and unsupportive data [20]. This can lead to polarisation, where different scientists draw
from different sources of evidence and arrive at opposing conclusions to similar questions
[27]. Unlike these two studies, which examined recent citation practices, the present study
focused on a historic analysis of divergent citation practices amongst papers drawing different
conclusions as to what the available empirical evidence supports. Citation bias and research
underutilisation were exactly documented, as were the different citation behaviours of differ-
ent classifications of review.
This case study was chosen because it represents a unique example where the relevant RCTs
were published in quick succession (1965–1968), and these remained the only RCTs address-
ing this particular question prior to a major consensus building conference in 1984. This pro-
vided a 17-year citation window, from the time all results of the RCTs were available to
researchers to the beginning of this conference, where the evidence-base, as derived from
RCTs, remained constant (i.e. no additional secondary prevention RCTs were published that
would have impacted the evidence-base and, possibly, citation behaviours). Further, as these
RCTs were the first to test this particular treatment, the relevant evidence-base and citation
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behaviour could not have been influenced by prior studies, at-least not evidence derived from
RCTs, which may have distorted the results. This provided a unique opportunity to study how
scientists utilise a small evidence-base over a long and undisturbed period. One surprising
findings is that, even with a small evidence-base, scientists did not generally cite these studies
in a representative manner nor did their citation behaviours improve as this period unfolded,
and this challenges our understanding that it may be the size of the literature responsible for
this phenomenon.
Therefore, the major findings of this study demonstrate that citation bias is not a new phe-
nomenon–challenging narratives that suggest our science has become increasingly less reliable
in recent years because science has grown too large–and that scientific disagreement may
revolve around something more simple than divergent theoretical positions–scientists may
just be looking at different sources of data.
The results of this study should not be taken as making claims about the current state of
knowledge regarding the efficacy of dietary intervention in secondary prevention. Nor should it
be used to fuel the current controversy over scientific advice concerning dietary fat consump-
tion. Indeed, the selection of a historical cases study was, in part, chosen to avoid this paper
being mistaken for attempting to weigh in on what particular treatment is suitable in secondary
prevention. Since the 1980s, much work has been conducted in this area and the results of this
study do not impact the scientific case. Rather, the aim was to provide a deeper understanding
of the ways in which empirical data is used by scientists, how it may fuel scientific disagreement,
and to introduce a method capable of detecting this particularly efficiently. Its focus was on cita-
tion practices and evidence dissemination, not the validity of current scientific theories.
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